Better Together: New Deal Adds Weight To China Biosimilar/Biobetter Swap
Executive Summary
Perhaps encouraged by the recent successful initial public offering of Innovent Bio, more biologics developers in China are turning towards innovative biologics and away from traditional biosimilars.